Company name | Market Cap | Quality rating | Intrinsic value | 1Y Return | Revenue | Free Cash Flow | Revenue growth | FCF margin | Gross margin | ROIC | Total Debt to Equity |
$2,933.9B | 7.0 | $438.3 12.8% undervalued | (5.8%) | $261.8B | $70.0B | 15.0% | 26.7% | 69.4% | 27.5% | 20.6% | |
$167.9B | 6.0 | $462.2 48.7% undervalued | 13.7% | $33.3B | $10.4B | 18.2% | 31.2% | 61.4% | 10.0% | 1,022.6% | |
$79.3B | 7.3 | $67.5 6.4% undervalued | 14.3% | $15.2B | $2,149.3M | 21.3% | 14.1% | 33.8% | 19.6% | 4.1% | |
$69.4B | 6.7 | $294.4 15.7% undervalued | (6.8%) | $8,438.0M | $2,192.0M | 16.5% | 26.0% | 80.2% | 4.2% | 4.2% | |
$61.5B | 6.4 | $177.6 62.7% undervalued | (25.9%) | £33.2B | £3,907.8M | 17.9% | 11.8% | 59.8% | 36.9% | 154.2% | |
$55.1B | 7.7 | $237.0 15.2% undervalued | (10.2%) | $6,229.8M | $2,556.8M | 100.4% | 41.0% | 86.0% | 136.1% | 3.8% | |
$43.1B | 5.4 | $35.4 48.6% undervalued | 26.3% | $30.3B | $998.1M | 24.1% | 3.3% | 29.2% | 1.2% | 79.1% | |
$40.3B | 6.8 | $158.8 82.7% undervalued | 28.5% | €37.2B | €3,823.0M | 31.7% | 10.3% | 36.3% | 15.9% | 137.0% | |
$29.8B | 7.1 | $230.3 5.0% undervalued | 169.1% | $13.7B | $827.0M | 26.9% | 6.0% | 20.4% | 20.6% | 52.6% | |
$26.5B | 7.4 | $257.1 63.9% undervalued | 74.8% | $4,215.6M | $985.6M | 15.4% | 23.4% | 79.7% | 8.1% | 419.5% | |
$21.7B | 6.6 | $63.2 71.6% undervalued | 51.0% | $4,960.0M | $306.0M | 28.3% | 6.2% | 24.0% | 3.3% | 1.6% | |
$20.1B | 5.7 | $6.6 40.2% undervalued | 54.1% | $2,686.0M | $609.0M | 21.6% | 22.7% | 41.6% | (42.5%) | 5.1% | |
$18.7B | 7.2 | $402.5 1.7% undervalued | 22.5% | $14.6B | $1,332.9M | 15.8% | 9.2% | 19.0% | 19.3% | 24.0% | |
$17.3B | 6.3 | $414.9 37.0% undervalued | (21.7%) | $40.6B | $544.0M | 19.2% | 1.3% | 34.7% | 33.0% | 69.4% | |
$17.0B | 5.2 | $12.3 26.1% undervalued | (11.4%) | $5,361.4M | $218.7M | 16.4% | 4.1% | 52.4% | (20.6%) | 173.2% | |
$16.8B | 6.2 | $82.9 76.4% undervalued | (26.9%) | $15.6B | $440.0M | 38.6% | 2.8% | 37.3% | 14.8% | 59.7% | |
$15.5B | 5.5 | $153.1 75.5% undervalued | (20.2%) | $2,533.0M | $616.0M | 16.8% | 24.3% | 76.1% | (2.9%) | 15.3% | |
$15.5B | 7.3 | $62.8 59.2% undervalued | 24.8% | $3,605.2M | $1,804.4M | 16.1% | 50.0% | 63.0% | 15.7% | 205.2% | |
$14.0B | 7.7 | $427.2 37.8% undervalued | 35.5% | $2,877.4M | $1,080.6M | 23.6% | 37.6% | 89.2% | 65.4% | 4.7% | |
$12.3B | 6.8 | $209.0 41.4% undervalued | 81.0% | $2,804.3M | $563.1M | 67.4% | 20.1% | 68.7% | 5.5% | 34.8% |
Stay informed on the latest stocks trading at 52-week lows, highlighting those facing downward pressure in the market.
Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
Discover high ROIC stocks in 2025 that generate returns on invested capital, driving sustainable growth and profitability.